![Gary Sender](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Sender
Director/Board Member at
SCHRÖDINGER, INC.
Net worth: 506 739 $ as of 31/08/2026
Profile
Mr. Gary L.
Sender is an Independent Director at iBio, Inc., an Independent Director at Harmony Biosciences Holdings, Inc., an Independent Director at Schrödinger, Inc. and a President at Sender Consulting LLC.
He is on the Board of Directors at Apnimed, Inc., Gennao Bio, Inc., Elucida Oncology, Inc., iBio, Inc., Harmony Biosciences Holdings, Inc., Schrödinger, Inc. and Harmony Biosciences LLC.
Mr. Sender was previously employed as a Chief Financial Officer by Nabriva Therapeutics GmbH, a Chief Financial Officer by Nabriva Therapeutics Plc, a Chief Financial Officer & Executive Vice President by Synergy Pharmaceuticals, Inc., a Senior Vice President-Finance by Shire Plc /Old/, a CFO, Vice President-Finance & Administration by Tengion, Inc., and a Head-Investor Relations & Treasury by Merck & Co. He received his undergraduate degree from Boston University and an MBA from Carnegie Mellon University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SCHRODINGER, INC. 0.04% | 22/06/2026 | 25,388 ( 0.04% ) | 495 066 $ | 31/08/2026 |
IBIO, INC. 0.03% | 01/09/2026 | 9,191 ( 0.03% ) | 11 673 $ | 31/08/2026 |
APNIMED, INC. -.--% | 03/08/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| 14/05/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Gary Sender active positions
| Companies | Position | Start |
|---|---|---|
| SCHRÖDINGER, INC. | Director/Board Member | 01/07/2019 |
| IBIO, INC. | Director/Board Member | 14/10/2020 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Director/Board Member | 01/08/2020 |
| APNIMED, INC. | Director/Board Member | 01/10/2024 |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Director/Board Member | 29/04/2021 |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Director/Board Member | - |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Director/Board Member | 08/09/2021 |
Former positions of Gary Sender
| Companies | Position | End |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Director of Finance/CFO | 12/03/2021 |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Director of Finance/CFO | 23/06/2017 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░ ░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Gary Sender
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Tengion, Inc.
 Tengion, Inc. BiotechnologyHealth Technology Develops new human organs and tissues | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schrödinger, Inc.
 Schrödinger, Inc. Packaged SoftwareTechnology Services Develops physics-based software platform which enables discovery of novel molecules for drug development and materials applications | Technology Services |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Health Technology |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Health Technology |
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Engages in developing and commercializing of proprietary therapeutics for sleep apnea & breathing diseases | Health Technology |
Merck & Co.
 Merck & Co. Real Estate DevelopmentFinance Operators of Nonresidential Buildings | Finance |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted nucleic acid therapeutics to cure muscle diseases | Health Technology |
- Stock Market
- Insiders
- Gary Sender
